These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18550198)

  • 1. AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects.
    Konishi K; Nakano S; Tsuda S; Nakagawa A; Kigoshi T; Koya D
    Diabetes Res Clin Pract; 2008 Sep; 81(3):310-5. PubMed ID: 18550198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study.
    Owada A; Nakao M; Koike J; Ujiie K; Tomita K; Shiigai T
    Kidney Int Suppl; 1997 Dec; 63():S188-90. PubMed ID: 9407455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
    Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
    J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
    Agarwal R
    Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF.
    Sanaka T; Fujimoto K; Niwayama J; Nishimura H; Naito T; Higuchi C; Akizawa T; Koide K; Koshikawa S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S35-7. PubMed ID: 12612949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure: two-year study.
    Takahashi N; Kawaguchi T; Suzuki T
    Int J Urol; 2005 Jan; 12(1):7-11. PubMed ID: 15661048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function.
    Atoh K; Itoh H; Haneda M
    Diabetes Res Clin Pract; 2009 Feb; 83(2):220-6. PubMed ID: 19027976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study.
    Hwang YC; Kim SW; Hur KY; Cha BS; Kim IJ; Park TS; Baik SH; Yoon KH; Lee KW; Lee IK; Lee MK
    J Korean Med Sci; 2019 Apr; 34(15):e117. PubMed ID: 31001934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tranilast in early-stage diabetic nephropathy.
    Soma J; Sato K; Saito H; Tsuchiya Y
    Nephrol Dial Transplant; 2006 Oct; 21(10):2795-9. PubMed ID: 16820373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.
    Niwa T; Tsukushi S; Ise M; Miyazaki T; Tsubakihara Y; Owada A; Shiigai T
    Miner Electrolyte Metab; 1997; 23(3-6):179-84. PubMed ID: 9387112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
    Sharma P; Kumar A; Shrama BC; Sarin SK
    Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
    Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of renal biopsy in type-II diabetic patients.
    Arif M; Arif MK; Arif MS
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):627-31. PubMed ID: 19811713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD.
    Schulman G; Agarwal R; Acharya M; Berl T; Blumenthal S; Kopyt N
    Am J Kidney Dis; 2006 Apr; 47(4):565-77. PubMed ID: 16564934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases.
    Ueda H; Shibahara N; Takagi S; Inoue T; Katsuoka Y
    Ther Apher Dial; 2007 Jun; 11(3):189-95. PubMed ID: 17498000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.